Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04542616
NA

Baerveldt 350 vs Ahmed ClearPath 250 for the Treatment of Glaucoma

Sponsor: State University of New York at Buffalo

View on ClinicalTrials.gov

Summary

To compare the safety and efficacy of Baerveldt 350 and Ahmed ClearPath 250 tube shunts in lowering IOP in glaucoma patients.

Official title: Outcomes Comparison Between Baerveldt 350 and Ahmed ClearPath 250 Tube Shunts for the Treatment of Glaucoma

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2020-08-13

Completion Date

2024-07-31

Last Updated

2026-04-17

Healthy Volunteers

No

Conditions

Interventions

DEVICE

Baerveldt 350 vs. Ahmed ClearPath 250 tube shunt implantation

Baerveldt 350 vs. Ahmed ClearPath 250 tube shunt implantation for the treatment of severe uncontrolled glaucoma.

Locations (1)

The Ira G. Ross Eye Institute

Buffalo, New York, United States